Aeolus Pharmaceuticals Inc (AOLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,842 | -7,620 | -25,869 | -12,981 | -8,358 |
| Depreciation Amortization | N/A | N/A | 1 | N/A | N/A |
| Accounts receivable | -785 | 0 | N/A | N/A | N/A |
| Other Working Capital | -960 | -280 | 689 | 59 | 203 |
| Other Operating Activity | 3,662 | 7,383 | 22,733 | 11,127 | 7,168 |
| Operating Cash Flow | $-1,925 | $-517 | $-2,446 | $-1,795 | $-987 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -7 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | -7 | 0 |
| Investing Cash Flow | $N/A | $N/A | $-7 | $-7 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,269 | 1,042 | 4,373 | 1,613 | 1,667 |
| Other Financing Activity | -13 | -13 | -211 | 0 | -54 |
| Financing Cash Flow | $1,256 | $1,029 | $4,162 | $1,613 | $1,613 |
| Beginning Cash Position | 2,355 | 2,355 | 646 | 646 | 646 |
| End Cash Position | 1,686 | 2,867 | 2,355 | 457 | 1,272 |
| Net Cash Flow | $-669 | $512 | $1,709 | $-189 | $626 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,925 | -517 | -2,446 | -1,795 | -987 |
| Capital Expenditure | N/A | N/A | -7 | N/A | N/A |
| Free Cash Flow | -1,925 | -517 | -2,453 | -1,795 | -987 |